nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—PTGS1—Alzheimer's disease	0.367	1	CbGaD
Montelukast—CYP2A6—Memantine—Alzheimer's disease	0.187	0.484	CbGbCtD
Montelukast—CYP2C9—Donepezil—Alzheimer's disease	0.0742	0.192	CbGbCtD
Montelukast—CYP3A4—Rivastigmine—Alzheimer's disease	0.054	0.14	CbGbCtD
Montelukast—CYP3A4—Donepezil—Alzheimer's disease	0.0432	0.112	CbGbCtD
Montelukast—CYP3A4—Galantamine—Alzheimer's disease	0.0278	0.072	CbGbCtD
Montelukast—Injury—Donepezil—Alzheimer's disease	0.000821	0.00444	CcSEcCtD
Montelukast—Bronchitis—Galantamine—Alzheimer's disease	0.00081	0.00437	CcSEcCtD
Montelukast—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.000806	0.00435	CcSEcCtD
Montelukast—Ear pain—Memantine—Alzheimer's disease	0.000803	0.00434	CcSEcCtD
Montelukast—Thirst—Donepezil—Alzheimer's disease	0.000793	0.00428	CcSEcCtD
Montelukast—Sleep disorder—Memantine—Alzheimer's disease	0.000792	0.00428	CcSEcCtD
Montelukast—Ear pain—Rivastigmine—Alzheimer's disease	0.000786	0.00424	CcSEcCtD
Montelukast—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.000782	0.00423	CcSEcCtD
Montelukast—Sleep disorder—Rivastigmine—Alzheimer's disease	0.000775	0.00418	CcSEcCtD
Montelukast—Gastroenteritis—Memantine—Alzheimer's disease	0.000773	0.00418	CcSEcCtD
Montelukast—Disorientation—Memantine—Alzheimer's disease	0.000766	0.00414	CcSEcCtD
Montelukast—Eczema—Memantine—Alzheimer's disease	0.000763	0.00412	CcSEcCtD
Montelukast—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.000756	0.00409	CcSEcCtD
Montelukast—Pneumonia—Galantamine—Alzheimer's disease	0.000755	0.00408	CcSEcCtD
Montelukast—Eczema—Rivastigmine—Alzheimer's disease	0.000746	0.00403	CcSEcCtD
Montelukast—Injury—Memantine—Alzheimer's disease	0.000746	0.00403	CcSEcCtD
Montelukast—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000736	0.00397	CcSEcCtD
Montelukast—Injury—Rivastigmine—Alzheimer's disease	0.000729	0.00394	CcSEcCtD
Montelukast—Irritability—Donepezil—Alzheimer's disease	0.00072	0.00389	CcSEcCtD
Montelukast—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00071	0.00383	CcSEcCtD
Montelukast—Epistaxis—Galantamine—Alzheimer's disease	0.000708	0.00382	CcSEcCtD
Montelukast—Thirst—Rivastigmine—Alzheimer's disease	0.000705	0.00381	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.00068	0.00367	CcSEcCtD
Montelukast—Cramp muscle—Donepezil—Alzheimer's disease	0.00068	0.00367	CcSEcCtD
Montelukast—Rhinitis—Galantamine—Alzheimer's disease	0.000676	0.00365	CcSEcCtD
Montelukast—Nasopharyngitis—Donepezil—Alzheimer's disease	0.000675	0.00365	CcSEcCtD
Montelukast—Hepatitis—Galantamine—Alzheimer's disease	0.000674	0.00364	CcSEcCtD
Montelukast—Hallucination—Galantamine—Alzheimer's disease	0.00067	0.00362	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000666	0.0036	CcSEcCtD
Montelukast—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000665	0.00359	CcSEcCtD
Montelukast—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000662	0.00358	CcSEcCtD
Montelukast—Urethral disorder—Galantamine—Alzheimer's disease	0.000661	0.00357	CcSEcCtD
Montelukast—Irritability—Memantine—Alzheimer's disease	0.000654	0.00353	CcSEcCtD
Montelukast—Asthma—Donepezil—Alzheimer's disease	0.000652	0.00352	CcSEcCtD
Montelukast—Influenza—Donepezil—Alzheimer's disease	0.000652	0.00352	CcSEcCtD
Montelukast—Eosinophilia—Donepezil—Alzheimer's disease	0.000646	0.00349	CcSEcCtD
Montelukast—Pancreatitis—Donepezil—Alzheimer's disease	0.00064	0.00346	CcSEcCtD
Montelukast—Bronchitis—Donepezil—Alzheimer's disease	0.000627	0.00339	CcSEcCtD
Montelukast—Cardiac disorder—Galantamine—Alzheimer's disease	0.000625	0.00338	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000617	0.00333	CcSEcCtD
Montelukast—Nasopharyngitis—Memantine—Alzheimer's disease	0.000613	0.00331	CcSEcCtD
Montelukast—Immune system disorder—Galantamine—Alzheimer's disease	0.000609	0.00329	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000604	0.00327	CcSEcCtD
Montelukast—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000604	0.00326	CcSEcCtD
Montelukast—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.0006	0.00324	CcSEcCtD
Montelukast—Asthma—Memantine—Alzheimer's disease	0.000592	0.0032	CcSEcCtD
Montelukast—Influenza—Memantine—Alzheimer's disease	0.000592	0.0032	CcSEcCtD
Montelukast—Mental disorder—Galantamine—Alzheimer's disease	0.00059	0.00319	CcSEcCtD
Montelukast—Pneumonia—Donepezil—Alzheimer's disease	0.000585	0.00316	CcSEcCtD
Montelukast—Infestation NOS—Donepezil—Alzheimer's disease	0.000582	0.00314	CcSEcCtD
Montelukast—Infestation—Donepezil—Alzheimer's disease	0.000582	0.00314	CcSEcCtD
Montelukast—Pancreatitis—Memantine—Alzheimer's disease	0.000581	0.00314	CcSEcCtD
Montelukast—Bronchitis—Memantine—Alzheimer's disease	0.00057	0.00308	CcSEcCtD
Montelukast—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000568	0.00307	CcSEcCtD
Montelukast—Jaundice—Donepezil—Alzheimer's disease	0.000567	0.00306	CcSEcCtD
Montelukast—Conjunctivitis—Donepezil—Alzheimer's disease	0.000565	0.00305	CcSEcCtD
Montelukast—Muscle spasms—Galantamine—Alzheimer's disease	0.000564	0.00305	CcSEcCtD
Montelukast—Bronchitis—Rivastigmine—Alzheimer's disease	0.000557	0.00301	CcSEcCtD
Montelukast—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000551	0.00297	CcSEcCtD
Montelukast—Tremor—Galantamine—Alzheimer's disease	0.00055	0.00297	CcSEcCtD
Montelukast—Epistaxis—Donepezil—Alzheimer's disease	0.000549	0.00296	CcSEcCtD
Montelukast—Agitation—Galantamine—Alzheimer's disease	0.000539	0.00291	CcSEcCtD
Montelukast—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000539	0.00291	CcSEcCtD
Montelukast—CYSLTR1—nervous system—Alzheimer's disease	0.000537	0.0819	CbGeAlD
Montelukast—Pneumonia—Memantine—Alzheimer's disease	0.000531	0.00287	CcSEcCtD
Montelukast—Infestation—Memantine—Alzheimer's disease	0.000528	0.00285	CcSEcCtD
Montelukast—Infestation NOS—Memantine—Alzheimer's disease	0.000528	0.00285	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000524	0.00283	CcSEcCtD
Montelukast—Rhinitis—Donepezil—Alzheimer's disease	0.000524	0.00283	CcSEcCtD
Montelukast—Hepatitis—Donepezil—Alzheimer's disease	0.000522	0.00282	CcSEcCtD
Montelukast—Pneumonia—Rivastigmine—Alzheimer's disease	0.00052	0.00281	CcSEcCtD
Montelukast—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00052	0.00281	CcSEcCtD
Montelukast—Hallucination—Donepezil—Alzheimer's disease	0.00052	0.00281	CcSEcCtD
Montelukast—Palpitations—Galantamine—Alzheimer's disease	0.000518	0.0028	CcSEcCtD
Montelukast—Pharyngitis—Donepezil—Alzheimer's disease	0.000518	0.0028	CcSEcCtD
Montelukast—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000518	0.0028	CcSEcCtD
Montelukast—CYSLTR1—central nervous system—Alzheimer's disease	0.000517	0.0788	CbGeAlD
Montelukast—Infestation—Rivastigmine—Alzheimer's disease	0.000517	0.00279	CcSEcCtD
Montelukast—Drowsiness—Rivastigmine—Alzheimer's disease	0.000517	0.00279	CcSEcCtD
Montelukast—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000517	0.00279	CcSEcCtD
Montelukast—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000516	0.00279	CcSEcCtD
Montelukast—Conjunctivitis—Memantine—Alzheimer's disease	0.000513	0.00277	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000512	0.00277	CcSEcCtD
Montelukast—Urethral disorder—Donepezil—Alzheimer's disease	0.000512	0.00277	CcSEcCtD
Montelukast—Cough—Galantamine—Alzheimer's disease	0.000512	0.00276	CcSEcCtD
Montelukast—Convulsion—Galantamine—Alzheimer's disease	0.000508	0.00275	CcSEcCtD
Montelukast—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000506	0.00274	CcSEcCtD
Montelukast—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000502	0.00271	CcSEcCtD
Montelukast—Hepatobiliary disease—Memantine—Alzheimer's disease	0.0005	0.0027	CcSEcCtD
Montelukast—Myalgia—Galantamine—Alzheimer's disease	0.000499	0.0027	CcSEcCtD
Montelukast—Arthralgia—Galantamine—Alzheimer's disease	0.000499	0.0027	CcSEcCtD
Montelukast—Epistaxis—Memantine—Alzheimer's disease	0.000498	0.00269	CcSEcCtD
Montelukast—Anxiety—Galantamine—Alzheimer's disease	0.000498	0.00269	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000496	0.00268	CcSEcCtD
Montelukast—Sinusitis—Memantine—Alzheimer's disease	0.000496	0.00268	CcSEcCtD
Montelukast—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000489	0.00264	CcSEcCtD
Montelukast—Epistaxis—Rivastigmine—Alzheimer's disease	0.000487	0.00263	CcSEcCtD
Montelukast—Sinusitis—Rivastigmine—Alzheimer's disease	0.000485	0.00262	CcSEcCtD
Montelukast—Rhinitis—Memantine—Alzheimer's disease	0.000475	0.00257	CcSEcCtD
Montelukast—Hepatitis—Memantine—Alzheimer's disease	0.000474	0.00256	CcSEcCtD
Montelukast—Hypoaesthesia—Memantine—Alzheimer's disease	0.000472	0.00255	CcSEcCtD
Montelukast—Hallucination—Memantine—Alzheimer's disease	0.000472	0.00255	CcSEcCtD
Montelukast—Pharyngitis—Memantine—Alzheimer's disease	0.000471	0.00254	CcSEcCtD
Montelukast—Nervous system disorder—Galantamine—Alzheimer's disease	0.000469	0.00254	CcSEcCtD
Montelukast—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000469	0.00253	CcSEcCtD
Montelukast—Urinary tract disorder—Memantine—Alzheimer's disease	0.000468	0.00253	CcSEcCtD
Montelukast—Connective tissue disorder—Memantine—Alzheimer's disease	0.000466	0.00252	CcSEcCtD
Montelukast—Rhinitis—Rivastigmine—Alzheimer's disease	0.000465	0.00251	CcSEcCtD
Montelukast—Skin disorder—Galantamine—Alzheimer's disease	0.000465	0.00251	CcSEcCtD
Montelukast—Urethral disorder—Memantine—Alzheimer's disease	0.000465	0.00251	CcSEcCtD
Montelukast—Hepatitis—Rivastigmine—Alzheimer's disease	0.000464	0.00251	CcSEcCtD
Montelukast—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000462	0.00249	CcSEcCtD
Montelukast—Hallucination—Rivastigmine—Alzheimer's disease	0.000462	0.00249	CcSEcCtD
Montelukast—SLCO2B1—forebrain—Alzheimer's disease	0.000461	0.0703	CbGeAlD
Montelukast—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00046	0.00249	CcSEcCtD
Montelukast—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000458	0.00247	CcSEcCtD
Montelukast—Mental disorder—Donepezil—Alzheimer's disease	0.000458	0.00247	CcSEcCtD
Montelukast—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000456	0.00246	CcSEcCtD
Montelukast—PTGS1—blood vessel—Alzheimer's disease	0.000456	0.0695	CbGeAlD
Montelukast—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000455	0.00246	CcSEcCtD
Montelukast—Erythema multiforme—Memantine—Alzheimer's disease	0.000448	0.00242	CcSEcCtD
Montelukast—Cardiac disorder—Memantine—Alzheimer's disease	0.00044	0.00238	CcSEcCtD
Montelukast—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000439	0.00237	CcSEcCtD
Montelukast—Muscle spasms—Donepezil—Alzheimer's disease	0.000437	0.00236	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000436	0.00236	CcSEcCtD
Montelukast—Insomnia—Galantamine—Alzheimer's disease	0.000433	0.00234	CcSEcCtD
Montelukast—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00043	0.00233	CcSEcCtD
Montelukast—Paraesthesia—Galantamine—Alzheimer's disease	0.00043	0.00232	CcSEcCtD
Montelukast—Immune system disorder—Memantine—Alzheimer's disease	0.000428	0.00231	CcSEcCtD
Montelukast—Mediastinal disorder—Memantine—Alzheimer's disease	0.000427	0.00231	CcSEcCtD
Montelukast—Tremor—Donepezil—Alzheimer's disease	0.000426	0.0023	CcSEcCtD
Montelukast—Somnolence—Galantamine—Alzheimer's disease	0.000426	0.0023	CcSEcCtD
Montelukast—SLCO2B1—telencephalon—Alzheimer's disease	0.000424	0.0646	CbGeAlD
Montelukast—Dyspepsia—Galantamine—Alzheimer's disease	0.000421	0.00228	CcSEcCtD
Montelukast—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000418	0.00226	CcSEcCtD
Montelukast—Agitation—Donepezil—Alzheimer's disease	0.000418	0.00226	CcSEcCtD
Montelukast—Mental disorder—Memantine—Alzheimer's disease	0.000415	0.00224	CcSEcCtD
Montelukast—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000413	0.00223	CcSEcCtD
Montelukast—Fatigue—Galantamine—Alzheimer's disease	0.000413	0.00223	CcSEcCtD
Montelukast—CYSLTR1—brain—Alzheimer's disease	0.00041	0.0626	CbGeAlD
Montelukast—Mental disorder—Rivastigmine—Alzheimer's disease	0.000406	0.0022	CcSEcCtD
Montelukast—Cough—Donepezil—Alzheimer's disease	0.000397	0.00214	CcSEcCtD
Montelukast—Convulsion—Donepezil—Alzheimer's disease	0.000394	0.00213	CcSEcCtD
Montelukast—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000391	0.00211	CcSEcCtD
Montelukast—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000388	0.0021	CcSEcCtD
Montelukast—Myalgia—Donepezil—Alzheimer's disease	0.000387	0.00209	CcSEcCtD
Montelukast—Arthralgia—Donepezil—Alzheimer's disease	0.000387	0.00209	CcSEcCtD
Montelukast—Tremor—Memantine—Alzheimer's disease	0.000387	0.00209	CcSEcCtD
Montelukast—Anxiety—Donepezil—Alzheimer's disease	0.000386	0.00208	CcSEcCtD
Montelukast—Agitation—Memantine—Alzheimer's disease	0.000379	0.00205	CcSEcCtD
Montelukast—Abdominal pain—Galantamine—Alzheimer's disease	0.000378	0.00204	CcSEcCtD
Montelukast—Body temperature increased—Galantamine—Alzheimer's disease	0.000378	0.00204	CcSEcCtD
Montelukast—Tremor—Rivastigmine—Alzheimer's disease	0.000378	0.00204	CcSEcCtD
Montelukast—Agitation—Rivastigmine—Alzheimer's disease	0.000371	0.002	CcSEcCtD
Montelukast—Oedema—Donepezil—Alzheimer's disease	0.000371	0.002	CcSEcCtD
Montelukast—Infection—Donepezil—Alzheimer's disease	0.000369	0.00199	CcSEcCtD
Montelukast—Palpitations—Memantine—Alzheimer's disease	0.000365	0.00197	CcSEcCtD
Montelukast—Nervous system disorder—Donepezil—Alzheimer's disease	0.000364	0.00197	CcSEcCtD
Montelukast—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000363	0.00196	CcSEcCtD
Montelukast—Cough—Memantine—Alzheimer's disease	0.00036	0.00195	CcSEcCtD
Montelukast—Convulsion—Memantine—Alzheimer's disease	0.000358	0.00193	CcSEcCtD
Montelukast—Palpitations—Rivastigmine—Alzheimer's disease	0.000357	0.00193	CcSEcCtD
Montelukast—Hypersensitivity—Galantamine—Alzheimer's disease	0.000353	0.00191	CcSEcCtD
Montelukast—Cough—Rivastigmine—Alzheimer's disease	0.000352	0.0019	CcSEcCtD
Montelukast—Myalgia—Memantine—Alzheimer's disease	0.000351	0.0019	CcSEcCtD
Montelukast—Arthralgia—Memantine—Alzheimer's disease	0.000351	0.0019	CcSEcCtD
Montelukast—Anxiety—Memantine—Alzheimer's disease	0.00035	0.00189	CcSEcCtD
Montelukast—Convulsion—Rivastigmine—Alzheimer's disease	0.00035	0.00189	CcSEcCtD
Montelukast—Arthralgia—Rivastigmine—Alzheimer's disease	0.000344	0.00186	CcSEcCtD
Montelukast—Myalgia—Rivastigmine—Alzheimer's disease	0.000344	0.00186	CcSEcCtD
Montelukast—Asthenia—Galantamine—Alzheimer's disease	0.000343	0.00186	CcSEcCtD
Montelukast—Anxiety—Rivastigmine—Alzheimer's disease	0.000343	0.00185	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000341	0.00184	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000338	0.00183	CcSEcCtD
Montelukast—Oedema—Memantine—Alzheimer's disease	0.000337	0.00182	CcSEcCtD
Montelukast—Insomnia—Donepezil—Alzheimer's disease	0.000336	0.00181	CcSEcCtD
Montelukast—Infection—Memantine—Alzheimer's disease	0.000335	0.00181	CcSEcCtD
Montelukast—Paraesthesia—Donepezil—Alzheimer's disease	0.000333	0.0018	CcSEcCtD
Montelukast—Nervous system disorder—Memantine—Alzheimer's disease	0.00033	0.00178	CcSEcCtD
Montelukast—Somnolence—Donepezil—Alzheimer's disease	0.00033	0.00178	CcSEcCtD
Montelukast—Thrombocytopenia—Memantine—Alzheimer's disease	0.00033	0.00178	CcSEcCtD
Montelukast—Oedema—Rivastigmine—Alzheimer's disease	0.00033	0.00178	CcSEcCtD
Montelukast—Diarrhoea—Galantamine—Alzheimer's disease	0.000328	0.00177	CcSEcCtD
Montelukast—Infection—Rivastigmine—Alzheimer's disease	0.000327	0.00177	CcSEcCtD
Montelukast—Skin disorder—Memantine—Alzheimer's disease	0.000327	0.00177	CcSEcCtD
Montelukast—Dyspepsia—Donepezil—Alzheimer's disease	0.000327	0.00176	CcSEcCtD
Montelukast—ALOX5—nervous system—Alzheimer's disease	0.000325	0.0496	CbGeAlD
Montelukast—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000323	0.00175	CcSEcCtD
Montelukast—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000323	0.00174	CcSEcCtD
Montelukast—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00032	0.00173	CcSEcCtD
Montelukast—Skin disorder—Rivastigmine—Alzheimer's disease	0.00032	0.00173	CcSEcCtD
Montelukast—Fatigue—Donepezil—Alzheimer's disease	0.00032	0.00173	CcSEcCtD
Montelukast—Pain—Donepezil—Alzheimer's disease	0.000317	0.00171	CcSEcCtD
Montelukast—Dizziness—Galantamine—Alzheimer's disease	0.000317	0.00171	CcSEcCtD
Montelukast—ALOX5—central nervous system—Alzheimer's disease	0.000313	0.0477	CbGeAlD
Montelukast—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000307	0.00166	CcSEcCtD
Montelukast—ALOX5—cerebellum—Alzheimer's disease	0.000306	0.0466	CbGeAlD
Montelukast—Insomnia—Memantine—Alzheimer's disease	0.000305	0.00165	CcSEcCtD
Montelukast—Vomiting—Galantamine—Alzheimer's disease	0.000304	0.00164	CcSEcCtD
Montelukast—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000303	0.00164	CcSEcCtD
Montelukast—Paraesthesia—Memantine—Alzheimer's disease	0.000302	0.00163	CcSEcCtD
Montelukast—Rash—Galantamine—Alzheimer's disease	0.000302	0.00163	CcSEcCtD
Montelukast—Dermatitis—Galantamine—Alzheimer's disease	0.000302	0.00163	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.0003	0.00162	CcSEcCtD
Montelukast—Headache—Galantamine—Alzheimer's disease	0.0003	0.00162	CcSEcCtD
Montelukast—Somnolence—Memantine—Alzheimer's disease	0.000299	0.00162	CcSEcCtD
Montelukast—Insomnia—Rivastigmine—Alzheimer's disease	0.000298	0.00161	CcSEcCtD
Montelukast—Dyspepsia—Memantine—Alzheimer's disease	0.000297	0.0016	CcSEcCtD
Montelukast—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000296	0.0016	CcSEcCtD
Montelukast—Urticaria—Donepezil—Alzheimer's disease	0.000295	0.00159	CcSEcCtD
Montelukast—Abdominal pain—Donepezil—Alzheimer's disease	0.000293	0.00158	CcSEcCtD
Montelukast—Body temperature increased—Donepezil—Alzheimer's disease	0.000293	0.00158	CcSEcCtD
Montelukast—Somnolence—Rivastigmine—Alzheimer's disease	0.000293	0.00158	CcSEcCtD
Montelukast—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000291	0.00157	CcSEcCtD
Montelukast—Fatigue—Memantine—Alzheimer's disease	0.00029	0.00157	CcSEcCtD
Montelukast—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00029	0.00157	CcSEcCtD
Montelukast—Pain—Memantine—Alzheimer's disease	0.000288	0.00156	CcSEcCtD
Montelukast—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000285	0.00154	CcSEcCtD
Montelukast—Nausea—Galantamine—Alzheimer's disease	0.000284	0.00154	CcSEcCtD
Montelukast—Fatigue—Rivastigmine—Alzheimer's disease	0.000284	0.00153	CcSEcCtD
Montelukast—Pain—Rivastigmine—Alzheimer's disease	0.000282	0.00152	CcSEcCtD
Montelukast—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000275	0.00149	CcSEcCtD
Montelukast—Hypersensitivity—Donepezil—Alzheimer's disease	0.000273	0.00148	CcSEcCtD
Montelukast—CYP2A6—cerebellum—Alzheimer's disease	0.00027	0.0411	CbGeAlD
Montelukast—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000269	0.00146	CcSEcCtD
Montelukast—Urticaria—Memantine—Alzheimer's disease	0.000268	0.00145	CcSEcCtD
Montelukast—Abdominal pain—Memantine—Alzheimer's disease	0.000266	0.00144	CcSEcCtD
Montelukast—Body temperature increased—Memantine—Alzheimer's disease	0.000266	0.00144	CcSEcCtD
Montelukast—Asthenia—Donepezil—Alzheimer's disease	0.000266	0.00144	CcSEcCtD
Montelukast—Pruritus—Donepezil—Alzheimer's disease	0.000262	0.00142	CcSEcCtD
Montelukast—Urticaria—Rivastigmine—Alzheimer's disease	0.000262	0.00141	CcSEcCtD
Montelukast—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000261	0.00141	CcSEcCtD
Montelukast—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000261	0.00141	CcSEcCtD
Montelukast—Diarrhoea—Donepezil—Alzheimer's disease	0.000254	0.00137	CcSEcCtD
Montelukast—SLCO2B1—nervous system—Alzheimer's disease	0.00025	0.0382	CbGeAlD
Montelukast—ALOX5—brain—Alzheimer's disease	0.000249	0.0379	CbGeAlD
Montelukast—Hypersensitivity—Memantine—Alzheimer's disease	0.000248	0.00134	CcSEcCtD
Montelukast—Dizziness—Donepezil—Alzheimer's disease	0.000245	0.00133	CcSEcCtD
Montelukast—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000243	0.00131	CcSEcCtD
Montelukast—Asthenia—Memantine—Alzheimer's disease	0.000242	0.00131	CcSEcCtD
Montelukast—SLCO2B1—central nervous system—Alzheimer's disease	0.000241	0.0367	CbGeAlD
Montelukast—PTGS1—forebrain—Alzheimer's disease	0.00024	0.0366	CbGeAlD
Montelukast—Pruritus—Memantine—Alzheimer's disease	0.000238	0.00129	CcSEcCtD
Montelukast—Asthenia—Rivastigmine—Alzheimer's disease	0.000236	0.00128	CcSEcCtD
Montelukast—Vomiting—Donepezil—Alzheimer's disease	0.000236	0.00127	CcSEcCtD
Montelukast—SLCO2B1—cerebellum—Alzheimer's disease	0.000236	0.0359	CbGeAlD
Montelukast—Rash—Donepezil—Alzheimer's disease	0.000234	0.00126	CcSEcCtD
Montelukast—Dermatitis—Donepezil—Alzheimer's disease	0.000234	0.00126	CcSEcCtD
Montelukast—Pruritus—Rivastigmine—Alzheimer's disease	0.000233	0.00126	CcSEcCtD
Montelukast—Headache—Donepezil—Alzheimer's disease	0.000232	0.00126	CcSEcCtD
Montelukast—Diarrhoea—Memantine—Alzheimer's disease	0.00023	0.00124	CcSEcCtD
Montelukast—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000225	0.00122	CcSEcCtD
Montelukast—Dizziness—Memantine—Alzheimer's disease	0.000223	0.0012	CcSEcCtD
Montelukast—PTGS1—telencephalon—Alzheimer's disease	0.000221	0.0337	CbGeAlD
Montelukast—Nausea—Donepezil—Alzheimer's disease	0.00022	0.00119	CcSEcCtD
Montelukast—CYP2A6—brain—Alzheimer's disease	0.000219	0.0334	CbGeAlD
Montelukast—Dizziness—Rivastigmine—Alzheimer's disease	0.000218	0.00118	CcSEcCtD
Montelukast—Vomiting—Memantine—Alzheimer's disease	0.000214	0.00116	CcSEcCtD
Montelukast—Rash—Memantine—Alzheimer's disease	0.000212	0.00115	CcSEcCtD
Montelukast—Dermatitis—Memantine—Alzheimer's disease	0.000212	0.00115	CcSEcCtD
Montelukast—Headache—Memantine—Alzheimer's disease	0.000211	0.00114	CcSEcCtD
Montelukast—Vomiting—Rivastigmine—Alzheimer's disease	0.00021	0.00113	CcSEcCtD
Montelukast—Rash—Rivastigmine—Alzheimer's disease	0.000208	0.00112	CcSEcCtD
Montelukast—Dermatitis—Rivastigmine—Alzheimer's disease	0.000208	0.00112	CcSEcCtD
Montelukast—Headache—Rivastigmine—Alzheimer's disease	0.000206	0.00112	CcSEcCtD
Montelukast—Nausea—Memantine—Alzheimer's disease	0.0002	0.00108	CcSEcCtD
Montelukast—Nausea—Rivastigmine—Alzheimer's disease	0.000196	0.00106	CcSEcCtD
Montelukast—SLCO2B1—brain—Alzheimer's disease	0.000191	0.0292	CbGeAlD
Montelukast—PTGS1—nervous system—Alzheimer's disease	0.000131	0.0199	CbGeAlD
Montelukast—PTGS1—central nervous system—Alzheimer's disease	0.000126	0.0192	CbGeAlD
Montelukast—CYP2C8—brain—Alzheimer's disease	0.000123	0.0188	CbGeAlD
Montelukast—CYP3A4—nervous system—Alzheimer's disease	0.000109	0.0166	CbGeAlD
Montelukast—CYP3A4—central nervous system—Alzheimer's disease	0.000105	0.016	CbGeAlD
Montelukast—PTGS1—brain—Alzheimer's disease	9.98e-05	0.0152	CbGeAlD
Montelukast—ALOX5—Metabolism—PTGS1—Alzheimer's disease	3.83e-05	0.000701	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HSD17B10—Alzheimer's disease	3.81e-05	0.000698	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PLD3—Alzheimer's disease	3.76e-05	0.000688	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP2D6—Alzheimer's disease	3.75e-05	0.000687	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—F2—Alzheimer's disease	3.69e-05	0.000675	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP46A1—Alzheimer's disease	3.67e-05	0.000672	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PLCB1—Alzheimer's disease	3.62e-05	0.000663	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HSD17B10—Alzheimer's disease	3.61e-05	0.00066	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—BCHE—Alzheimer's disease	3.56e-05	0.000651	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—DHCR24—Alzheimer's disease	3.55e-05	0.00065	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ND1—Alzheimer's disease	3.55e-05	0.000649	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP46A1—Alzheimer's disease	3.47e-05	0.000635	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.47e-05	0.000634	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—IL6—Alzheimer's disease	3.46e-05	0.000634	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NGFR—Alzheimer's disease	3.38e-05	0.000619	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	3.37e-05	0.000616	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CREB1—Alzheimer's disease	3.36e-05	0.000615	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PLCB1—Alzheimer's disease	3.36e-05	0.000615	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ND1—Alzheimer's disease	3.35e-05	0.000614	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.31e-05	0.000606	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ADAM10—Alzheimer's disease	3.3e-05	0.000604	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	3.3e-05	0.000604	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.29e-05	0.000603	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CCL2—Alzheimer's disease	3.29e-05	0.000601	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ABCA1—Alzheimer's disease	3.26e-05	0.000596	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.26e-05	0.000596	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.17e-05	0.00058	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—S100B—Alzheimer's disease	3.12e-05	0.000571	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CA4—Alzheimer's disease	3.02e-05	0.000553	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF2—Alzheimer's disease	2.97e-05	0.000544	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.95e-05	0.00054	CbGpPWpGaD
Montelukast—CYP2A6—NRF2 pathway—TGFB1—Alzheimer's disease	2.9e-05	0.000531	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	2.89e-05	0.000529	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF1R—Alzheimer's disease	2.87e-05	0.000526	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GAPDHS—Alzheimer's disease	2.84e-05	0.00052	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PPARGC1A—Alzheimer's disease	2.81e-05	0.000513	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—HMOX1—Alzheimer's disease	2.79e-05	0.000511	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—LPL—Alzheimer's disease	2.76e-05	0.000504	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.73e-05	0.0005	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MEF2C—Alzheimer's disease	2.73e-05	0.0005	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.7e-05	0.000494	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ATP5A1—Alzheimer's disease	2.69e-05	0.000493	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PRKCG—Alzheimer's disease	2.68e-05	0.00049	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NGF—Alzheimer's disease	2.61e-05	0.000478	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PLD3—Alzheimer's disease	2.57e-05	0.00047	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.57e-05	0.00047	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—LPL—Alzheimer's disease	2.55e-05	0.000467	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.54e-05	0.000465	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCR5—Alzheimer's disease	2.54e-05	0.000465	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.49e-05	0.000455	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HTR2A—Alzheimer's disease	2.48e-05	0.000455	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HSD17B10—Alzheimer's disease	2.46e-05	0.000451	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CA4—Alzheimer's disease	2.46e-05	0.00045	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.41e-05	0.000441	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.4e-05	0.00044	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP46A1—Alzheimer's disease	2.37e-05	0.000434	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CALM1—Alzheimer's disease	2.32e-05	0.000424	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	2.31e-05	0.000423	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—LEP—Alzheimer's disease	2.31e-05	0.000423	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—APOE—Alzheimer's disease	2.31e-05	0.000423	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—MTHFR—Alzheimer's disease	2.3e-05	0.000421	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ND1—Alzheimer's disease	2.29e-05	0.000419	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CAV1—Alzheimer's disease	2.29e-05	0.000419	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CHAT—Alzheimer's disease	2.28e-05	0.000418	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TPI1—Alzheimer's disease	2.28e-05	0.000418	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.24e-05	0.00041	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ESR1—Alzheimer's disease	2.21e-05	0.000404	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	2.19e-05	0.000401	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MAOB—Alzheimer's disease	2.19e-05	0.000401	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—F2—Alzheimer's disease	2.18e-05	0.000399	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CHAT—Alzheimer's disease	2.16e-05	0.000395	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TPI1—Alzheimer's disease	2.16e-05	0.000395	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CALM1—Alzheimer's disease	2.15e-05	0.000393	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—APOE—Alzheimer's disease	2.14e-05	0.000392	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.13e-05	0.00039	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CAV1—Alzheimer's disease	2.12e-05	0.000388	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GAPDH—Alzheimer's disease	2.11e-05	0.000386	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PLD3—Alzheimer's disease	2.09e-05	0.000383	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.09e-05	0.000383	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.08e-05	0.000381	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MAOB—Alzheimer's disease	2.07e-05	0.000379	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.07e-05	0.000378	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.07e-05	0.000378	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.05e-05	0.000375	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—A2M—Alzheimer's disease	2.04e-05	0.000373	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	2.01e-05	0.000367	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GSK3B—Alzheimer's disease	2e-05	0.000366	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GAPDH—Alzheimer's disease	1.99e-05	0.000365	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CREB1—Alzheimer's disease	1.98e-05	0.000363	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—INS—Alzheimer's disease	1.97e-05	0.000361	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.96e-05	0.000359	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCL2—Alzheimer's disease	1.94e-05	0.000355	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.93e-05	0.000353	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—A2M—Alzheimer's disease	1.93e-05	0.000352	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF1—Alzheimer's disease	1.91e-05	0.000349	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.91e-05	0.000349	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PPARG—Alzheimer's disease	1.87e-05	0.000341	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.86e-05	0.000341	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—INS—Alzheimer's disease	1.83e-05	0.000335	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.82e-05	0.000333	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.82e-05	0.000332	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ACHE—Alzheimer's disease	1.77e-05	0.000324	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.76e-05	0.000323	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—INPP5D—Alzheimer's disease	1.75e-05	0.00032	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOS3—Alzheimer's disease	1.73e-05	0.000317	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ACHE—Alzheimer's disease	1.68e-05	0.000307	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.67e-05	0.000305	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ENO1—Alzheimer's disease	1.66e-05	0.000304	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—INPP5D—Alzheimer's disease	1.66e-05	0.000303	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP2D6—Alzheimer's disease	1.63e-05	0.000298	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.62e-05	0.000297	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.61e-05	0.000294	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—NOS3—Alzheimer's disease	1.6e-05	0.000294	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS1—Alzheimer's disease	1.57e-05	0.000287	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ENO1—Alzheimer's disease	1.57e-05	0.000287	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—BCHE—Alzheimer's disease	1.54e-05	0.000282	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP2D6—Alzheimer's disease	1.54e-05	0.000282	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.53e-05	0.000279	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.48e-05	0.000271	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CHAT—Alzheimer's disease	1.48e-05	0.00027	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TPI1—Alzheimer's disease	1.48e-05	0.00027	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CASP3—Alzheimer's disease	1.47e-05	0.000269	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS2—Alzheimer's disease	1.47e-05	0.000268	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6—Alzheimer's disease	1.46e-05	0.000267	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—BCHE—Alzheimer's disease	1.46e-05	0.000267	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PLCB1—Alzheimer's disease	1.46e-05	0.000266	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.45e-05	0.000265	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.44e-05	0.000263	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.43e-05	0.000261	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.41e-05	0.000259	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ABCA1—Alzheimer's disease	1.41e-05	0.000258	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.38e-05	0.000252	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PLCB1—Alzheimer's disease	1.38e-05	0.000252	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.36e-05	0.000249	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK8—Alzheimer's disease	1.35e-05	0.000247	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT1—Alzheimer's disease	1.35e-05	0.000246	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.35e-05	0.000246	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ABCA1—Alzheimer's disease	1.33e-05	0.000244	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.33e-05	0.000244	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.32e-05	0.000242	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.32e-05	0.000241	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.31e-05	0.000239	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.27e-05	0.000233	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—Alzheimer's disease	1.25e-05	0.000228	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.23e-05	0.000225	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	1.22e-05	0.000223	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HMOX1—Alzheimer's disease	1.21e-05	0.000222	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.2e-05	0.00022	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.2e-05	0.00022	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.17e-05	0.000215	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.15e-05	0.000211	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARGC1A—Alzheimer's disease	1.15e-05	0.000211	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HMOX1—Alzheimer's disease	1.15e-05	0.00021	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TGFB1—Alzheimer's disease	1.14e-05	0.000209	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.14e-05	0.000209	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.13e-05	0.000207	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.11e-05	0.000203	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—LPL—Alzheimer's disease	1.11e-05	0.000203	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.1e-05	0.000201	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.09e-05	0.000199	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.07e-05	0.000196	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.07e-05	0.000196	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.07e-05	0.000196	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.05e-05	0.000192	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—LPL—Alzheimer's disease	1.05e-05	0.000192	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MTHFR—Alzheimer's disease	9.97e-06	0.000182	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—BCHE—Alzheimer's disease	9.97e-06	0.000182	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.55e-06	0.000175	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MTHFR—Alzheimer's disease	9.43e-06	0.000173	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—Alzheimer's disease	9.42e-06	0.000172	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	9.41e-06	0.000172	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CALM1—Alzheimer's disease	9.32e-06	0.00017	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ACHE—Alzheimer's disease	9.31e-06	0.00017	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APOE—Alzheimer's disease	9.28e-06	0.00017	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.23e-06	0.000169	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	9.21e-06	0.000168	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CAV1—Alzheimer's disease	9.2e-06	0.000168	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	9.12e-06	0.000167	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CALM1—Alzheimer's disease	8.81e-06	0.000161	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APOE—Alzheimer's disease	8.78e-06	0.000161	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	8.73e-06	0.00016	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ENO1—Alzheimer's disease	8.73e-06	0.00016	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CAV1—Alzheimer's disease	8.7e-06	0.000159	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—Alzheimer's disease	8.62e-06	0.000158	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	8.56e-06	0.000157	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—BCHE—Alzheimer's disease	8.11e-06	0.000148	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARG—Alzheimer's disease	8.09e-06	0.000148	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT1—Alzheimer's disease	7.96e-06	0.000146	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—INS—Alzheimer's disease	7.93e-06	0.000145	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TPI1—Alzheimer's disease	7.92e-06	0.000145	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CHAT—Alzheimer's disease	7.92e-06	0.000145	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	7.86e-06	0.000144	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	7.82e-06	0.000143	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	7.66e-06	0.00014	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARG—Alzheimer's disease	7.65e-06	0.00014	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MAOB—Alzheimer's disease	7.59e-06	0.000139	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.51e-06	0.000137	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—INS—Alzheimer's disease	7.5e-06	0.000137	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	7.42e-06	0.000136	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKT1—Alzheimer's disease	7.37e-06	0.000135	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	7.31e-06	0.000134	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LPL—Alzheimer's disease	7.15e-06	0.000131	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—A2M—Alzheimer's disease	7.06e-06	0.000129	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NOS3—Alzheimer's disease	6.96e-06	0.000127	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NOS3—Alzheimer's disease	6.58e-06	0.00012	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	6.44e-06	0.000118	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	6.4e-06	0.000117	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	6.37e-06	0.000117	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—Alzheimer's disease	6.36e-06	0.000116	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ACHE—Alzheimer's disease	6.14e-06	0.000112	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	6.07e-06	0.000111	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CALM1—Alzheimer's disease	6.02e-06	0.00011	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	6.02e-06	0.00011	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOE—Alzheimer's disease	6e-06	0.00011	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CAV1—Alzheimer's disease	5.94e-06	0.000109	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LPL—Alzheimer's disease	5.82e-06	0.000107	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.76e-06	0.000105	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.76e-06	0.000105	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.64e-06	0.000103	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.35e-06	9.79e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	5.24e-06	9.59e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARG—Alzheimer's disease	5.22e-06	9.56e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—INS—Alzheimer's disease	5.12e-06	9.38e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	5.05e-06	9.24e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4.9e-06	8.96e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.89e-06	8.96e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOE—Alzheimer's disease	4.88e-06	8.93e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.84e-06	8.85e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NOS3—Alzheimer's disease	4.49e-06	8.22e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARG—Alzheimer's disease	4.25e-06	7.78e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.22e-06	7.72e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.2e-06	7.68e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—INS—Alzheimer's disease	4.17e-06	7.63e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	4.11e-06	7.52e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.84e-06	7.03e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.66e-06	6.69e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.46e-06	6.33e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.34e-06	6.12e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.23e-06	5.91e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.22e-06	5.89e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKT1—Alzheimer's disease	3.2e-06	5.85e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.19e-06	5.84e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKT1—Alzheimer's disease	3.02e-06	5.53e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.8e-06	5.13e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—INS—Alzheimer's disease	2.75e-06	5.03e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.41e-06	4.41e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.21e-06	4.04e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKT1—Alzheimer's disease	2.07e-06	3.78e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.68e-06	3.08e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.11e-06	2.03e-05	CbGpPWpGaD
